Explore more publications!

Sci-Tech Times Uzbekistan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Times Uzbekistan.

Press releases published on April 7, 2026

Neuroscale AI Joins HPE Unleash AI Partner Program to Bring Signal-Based, Agentic Recruiting to Enterprise AI Deployments
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
Nurix Therapeutics to Participate in Upcoming Investor Conference
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
Neuronetics Comments on Letter from Pointillist Family Office
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
Vantage Hemp Co. Engages ACOs and GPOs to Advance Participation in CMS CBD Pilot Program
Virtune AB (Publ) („Virtune“) hat die Neugewichtung für März 2026 des Virtune Stablecoin Index ETP durchgeführt
Virtune AB (Publ) (“Virtune”) har genomfört rebalanseringen för mars 2026 av Virtune Stablecoin Index ETP
Virtune AB (Publ) ("Virtune") has completed the rebalancing for March 2026 of its Virtune Stablecoin Index ETP
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
Equativ hilft Werbetreibenden, die Aufmerksamkeit der Zuschauer durch Creative Enhancements zurückzugewinnen
Equativ helps advertisers reclaim viewer attention with Creative Enhancements

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions